BDBM319754 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)-3,4-dihydroquinolin-2(1H)-one::US10174011, Example 22
SMILES: O=C1CCc2ccc(CCCCN3CCN(CC3)c3cccc4sccc34)cc2N1
InChI Key: InChIKey=DVWFBFACSVVQQZ-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM319754 (7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)buty...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.16 | n/a | n/a | n/a | n/a | n/a | n/a |
SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES; SUZHOU VIGONVITA LIFE SCIENCES CO., LTD.; TOPHARMAN SHANDONG CO., LTD. US Patent | Assay Description The D2 receptor agonism activity test (The agonism activity of test compounds on D2 receptor expressing human recombinant D2 receptor in HEK293 cells... | US Patent US10174011 (2019) BindingDB Entry DOI: 10.7270/Q2VH5QX7 | |||||||||||
More data for this Ligand-Target Pair |